From March 10, 2022 to June 30, 2022, the company has repurchased 3,620,000 shares, representing 0.5% for CNY 27.3 million. With this, the company has completed the repurchase of 3,620,000 shares, representing 0.5% for CNY 27.3 million under the buyback announced on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5 CNY | +6.16% | +1.63% | -9.58% |
1st Jan change | Capi. | |
---|---|---|
-9.58% | 457M | |
+19.08% | 43.46B | |
+24.43% | 22.61B | |
+16.67% | 15.15B | |
+22.78% | 14.83B | |
+57.41% | 13.08B | |
-0.05% | 6.79B | |
-12.44% | 6.72B | |
-8.87% | 5.73B | |
+12.71% | 5.45B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on March 10, 2022.